Silcort exerts an inhibitory influence on mechanisms and tissue modifications associated with inflammation. It decreases vascular permeability and exudation and the migration of inflammatory cells is markedly inhibited. In addition, systemic manifestations, such as fever and signs of Toxemia, can be suppressed. In infections characterized by acute toxicity, therapy with Silcort in conjunction with other appropriate antibacterial therapy is effective in reducing morbidity and mortality.


There are no reviews yet.

Be the first to review “Silcort”

Your email address will not be published. Required fields are marked *